IPI publication: Non-clinical safety evaluation of vaccines accelerating clinical development
International Pharmaceutical Industry: Sebastian Joseph discusses regulatory expectations for the non-clinical development of vaccines
Posted:
ReadChemistry Today publication: Non-clinical safety evaluation of vaccines accelerating clinical development
Chemistry Today: Sebastian Joseph discusses regulatory expectations for the non-clinical development of vaccines
Posted:
ReadSupporting M&As in the pharmaceutical/biopharmaceutical industry
Manufacturing Chemist: At PharmaLex, we believe we have a unique understanding of the cultural challenges experienced during M&As. Having merged ourselves in 2017 into PharmaLex, we have insight in how to overcome the challenges of maintaining agility while benefiting from working in a bigger corporate environment, having economies of scale with an increased resource pool.
Posted:
ReadNon-clinical safety evaluation of vaccines part II
Manufacturing Chemist: Sebastian Joseph discusses regulatory expectations for the non-clinical development of vaccines
Posted:
ReadNon-clinical safety evaluation of vaccines part I
Manufacturing Chemist: Sebastian Joseph discusses regulatory expectations for the non-clinical development of vaccines
Posted:
ReadMoving From Artificial Trials To Smarter Regulatory Process
PharmaLex’s Bruno Boulanger discusses the impact big data will have on how the pharmaceutical industry gathers and delivers data in the future. *subscription required*
Posted:
Read